The rise of AI-powered platforms is transforming biomedical research—from Ultrack’s state-of-the-art cell tracking in embryology to MARQO's computational cancer tissue analysis. Novel pipelines leverage AI for precision cancer therapy personalization and accelerate catalytic pathway design. In drug discovery, advances such as BindCraft’s one-shot protein binder design and VantAI-Halda Therapeutics’ $1 billion collaboration for AI-enabled cancer treatments showcase AI’s expanding role in accelerating innovation across life sciences.